Dana Farber Cancer Institute; Dept Dana-Farber Cancer Inst

450 Brookline Avenue
Boston, Massachusetts 02215

We've found

1 trials

at this facility

A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Boston, MA

Use our guide to learn which trials are right for you!